上海盟科药业股份有限公司 股东询价转让定价情况提示性公告

Group 1 - The initial transfer price determined for the share transfer is 6.57 yuan per share based on the inquiry conducted on August 22, 2025 [2][3] - The transfer process will include an additional subscription procedure, with the deadline for this process set no later than September 4, 2025 [3] - The transfer does not involve a change in company control and will not affect the company's governance structure or ongoing operations [3] Group 2 - The announcement confirms that the information provided by the transferors is accurate and complete, and they bear legal responsibility for any misrepresentation [1][4] - The final results of the share transfer will depend on the processing by the China Securities Depository and Clearing Corporation Limited, Shanghai Branch [3]